Edition:
United Kingdom

Reata Pharmaceuticals Inc (RETA.OQ)

RETA.OQ on NASDAQ Stock Exchange Global Market

59.47USD
14 Dec 2018
Change (% chg)

$-1.96 (-3.19%)
Prev Close
$61.43
Open
$60.66
Day's High
$61.51
Day's Low
$59.44
Volume
75,418
Avg. Vol
97,968
52-wk High
$99.26
52-wk Low
$19.32

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 5.18 -1.074
Jun '18 7.57 -1.078
Mar '18 32.39 0.153
FY 2017 Dec '17 9.96 -0.638
Sep '17 12.56 -0.495
Jun '17 12.81 -0.518
Mar '17 12.73 -0.318
FY 2016 Dec '16 12.50 -0.185
Sep '16 12.55 -0.040
Jun '16 12.37 -0.050
Mar '16 12.44 -0.013
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 6.07 7.60 5.00 9.77
Quarter Ending Mar-19 2 6.13 7.50 4.77 7.05
Year Ending Dec-18 6 51.09 52.74 49.45 47.02
Year Ending Dec-19 6 28.21 45.00 19.06 53.17
Earnings (per share)
Quarter Ending Dec-18 7 -1.07 -0.95 -1.21 -0.52
Quarter Ending Mar-19 4 -1.07 -1.00 -1.12 -0.67
Year Ending Dec-18 7 -3.11 -3.01 -3.21 -2.42
Year Ending Dec-19 7 -4.52 -3.77 -5.30 -3.33
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 16.46 49.58 6.22
Price to Book (MRQ) -- 10.17 5.20
Price to Tangible Book (MRQ) -- 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 38.46 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 3.56 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago 1.53 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -927.87 75.90 23.09
EPS (TTM) vs TTM 1 Yr. Ago -792.05 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 1.34 3.44 3.10
LT Debt to Equity (MRQ) -- 18.69 11.49
Total Debt to Equity (MRQ) -- 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -45.39 -- --
EBITD - 5 Yr. Avg -- -110.03 13.16
Operating Margin (TTM) -46.57 -185.03 6.07
Operating Margin - 5 Yr. Avg. -- -126.47 8.47
Pre-Tax Margin (TTM) -46.88 -175.80 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.63 8.71
Net Profit Margin (TTM) -46.89 -182.53 3.12
Net Profit Margin - 5 Yr. Avg. -- -137.03 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 674,533 7,648,872 873,051,409
Net Income/Employee (TTM) -316,293 653,324 103,483,755
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.54 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -25.54 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) -63.77 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) -- 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.40 17.37
  1 Year 3 Year 5 Year
Sales % -0.92 -0.88 --
EPS (TTM) % -333.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Reata Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 10.50 6.69 69 98
13 Week -0.75 -5.58 47 94
26 Week 39.91 29.28 78 98
52 Week 13.89 -3.47 60 68
YTD 46.13 28.33 71 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.35%
# of Holders: 175
Total Shares Held: 16,398,474
3 Mo. Net Change: 3,607,235
# New Positions: 42
# Closed Positions: 11
# Increased Positions: 107
# Reduced Positions: 54
# Net Buyers: 53
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.